A detoxification method includes the steps of inducing flow of patient blood through an extracorporeal device inlet and outlet in fluid connection to the circulatory system of a patient. Biological agents including lipopolysaccharide (LPS) contained within patient blood can be detoxified by passing patient blood over a biochemical reactor surface having attached or immobilized Saccharomyces boulardii alkaline phosphatase enzyme, with the biochemical reactor being contained within the extracorporeal device.

An assay kit of reagents including a nucleic acid capable of acting as substrate for polymerase microorganism activity useful in a method of detecting polymerase activity as an indicator of the presence of a micro-organism in a sample are disclosed. The disclosed embodiments also relate to reagents for use in such methods, and to test kits comprising such reagents for carrying out the methods.

An assay kit of reagents including a nucleic acid capable of acting as substrate for polymerase microorganism activity useful in a method of detecting polymerase activity as an indicator of the presence of a micro-organism in a sample are disclosed. The disclosed embodiments also relate to reagents for use in such methods, and to test kits comprising such reagents for carrying out the methods.

This invention provides a technology of DNA methylation analysis including:

(1) a step of digesting DNA to be analyzed with a restriction enzyme(s) containing methylated cytosine or possibly methylated cytosine in a recognition sequence(s), wherein the recognition site is affected by the methylation;
(2) a step of treating the mixture of DNA fragments obtained in the step (1) with ligase to ligate them;
(3) a step of determining the base sequence of each DNA constructs included in the mixture of DNA constructs obtained in the step (2); and
(4) a step of comparing the base sequence information of each recognition sites and its surrounding sequences, obtained in the step (3), to a known genome sequence; determining whether said each recognition site is not cleaved with said restriction enzyme or cleaved with said restriction enzyme then regenerated by ligation with said ligase; and finally, determining each methylation states of each recognition sites.

This invention provides a technology of DNA methylation analysis including:

(1) a step of digesting DNA to be analyzed with a restriction enzyme(s) containing methylated cytosine or possibly methylated cytosine in a recognition sequence(s), wherein the recognition site is affected by the methylation;
(2) a step of treating the mixture of DNA fragments obtained in the step (1) with ligase to ligate them;
(3) a step of determining the base sequence of each DNA constructs included in the mixture of DNA constructs obtained in the step (2); and
(4) a step of comparing the base sequence information of each recognition sites and its surrounding sequences, obtained in the step (3), to a known genome sequence; determining whether said each recognition site is not cleaved with said restriction enzyme or cleaved with said restriction enzyme then regenerated by ligation with said ligase; and finally, determining each methylation states of each recognition sites.

The invention provides novel methods and compositions for diagnosing, treating, and monitoring treatment of Shank3 (SH3 and multiple ankyrin repeat domains 3) deficiency associated disorders.

The invention provides novel methods and compositions for diagnosing, treating, and monitoring treatment of Shank3 (SH3 and multiple ankyrin repeat domains 3) deficiency associated disorders.

Methods for detecting microorganisms, in particular detection of bacteria and methods for measuring enzyme activity, such as Deoxyribonucleic acid (DNA) polymerase activity are disclosed. The aforesaid methods include, but are not limited to such methods performed on microbial crude lysates, useful for determining microbial enzyme activities, which can be linked to amplification signal generators such as real-time Polymerase Chain Reaction (PCR) techniques, thereby enabling determination of microbial pathogens in samples such as unpurified blood and other body fluids. Moreover, the disclosed embodiments also relate to reagents for use in such methods, and to test kits comprising such reagents for carrying out the methods.

Methods for detecting microorganisms, in particular detection of bacteria and methods for measuring enzyme activity, such as Deoxyribonucleic acid (DNA) polymerase activity are disclosed. The aforesaid methods include, but are not limited to such methods performed on microbial crude lysates, useful for determining microbial enzyme activities, which can be linked to amplification signal generators such as real-time Polymerase Chain Reaction (PCR) techniques, thereby enabling determination of microbial pathogens in samples such as unpurified blood and other body fluids. Moreover, the disclosed embodiments also relate to reagents for use in such methods, and to test kits comprising such reagents for carrying out the methods.

The invention relates to an enzymatically responsive product that includes an amino acid residue conjugated to a magnetic particle, wherein the amino acid residue is phosphorylated or sulfated or comprises an ester-moiety linked via peptide bond. Compositions containing the enzymatically responsive product, and the use thereof for separating distinct types of mammalian cells (e.g., cancer cells from normal cells), for treating a cancerous condition, and imaging cancer cells are also disclosed.